267 results on '"Levitt, Daniel"'
Search Results
52. Treatment of HIV-associated Kaposi's sarcoma with aldoxorubicin.
53. Phase 1b study of aldoxorubicin + gemcitabine in metastatic solid tumors.
54. Phase 2 study of aldoxorubicin in relapsed glioblastoma.
55. A phase 1/2 study of continuous infusion ifosfamide/mesna + aldoxorubicin in sarcoma patients.
56. Efficacy and safety of tamibarotene or placebo added to paclitaxel/carboplatin for advanced non-small cell lung cancer.
57. Model for other schools.
58. Epstein-Barr virus-induced lymphoblastoid cell lines derived from the peripheral blood of patients with X-linked agammaglobulinemia can secrete IgM
59. Immunoglobulin isotype expression of normal pre-B cells as determined by immunofluorescence
60. Severe intrahepatic cholestasis in patients treated with recombinant interleukin-2 and lymphokine-activated killer cells
61. How To Acquire Top Talent Like A Major League Baseball General Manager.
62. Efficacy and safety of adding the retinoid tamibarotene or placebo to paclitaxel/carboplatin for advanced non-small cell lung cancer.
63. Longer term cardiac safety of aldoxorubicin.
64. Treatment of HIV-associated Kaposi's sarcoma with aldoxorubicin.
65. Pharmacokinetic study of aldoxorubicin in patients with solid tumors
66. A phase 1B/2 study of aldoxorubicin in patients with soft tissue sarcoma
67. Abstract 816: Antitumor efficacy of a novel anthracycline derivative aldoxorubicin in an orthotopic mouse model of glioblastoma
68. A Monoclonal Antibody Which Identifies a Subpopulation of Human B Lymphocytes and Monocytes
69. Chapter 4 Concepts and Mechanisms of Cartilage Differentiation
70. Thermal Modeling of High-Level Nuclear Waste Disposal in a Salt Repository
71. Pharmacokinetic study of aldoxorubicin in solid tumor patients.
72. Randomized phase 2b trial comparing first-line treatment with aldoxorubicin versus doxorubicin in patients with advanced soft tissue sarcomas.
73. Ed Barrow
74. Pharmacokinetic study of aldoxorubicin in solid tumor patients.
75. Phase Ib trial of combining aldoxorubicin plus doxorubicin.
76. Introduction
77. Phase Ib/II study of INNO-206 (EMCH-doxorubicin) in patients with soft tissue sarcoma.
78. Abstract 1801: Lyn and Fyn inhibition as a potential novel treatment for glioblastoma multiforme
79. A Pilot Phase II Study of the Lyn Kinase Inhibitor Bafetinib in Patients with Relapsed or Refractory B Cell Chronic Lymphocytic Leukemia
80. Successful Treatment of Relapsed and Refractory Extramedullary Acute Promyelocytic Leukemia With Tamibarotene
81. Abstract LB-305: The tyrosine kinase inhibitor bafetinib (INNO-406) inhibits osteoclast formation and bone resorption
82. Stepwise inversion of a groundwater flow model with multi-scale observation data
83. 389 A Randomized, Double-Blind, Placebo-Controlled Trial of Basiliximab with Concomitant Corticosteroids in Steroid-Refractory Ulcerative Colitis
84. The Making of Ed Barrow
85. Surface Water-Groundwater Connection at the Los Alamos Canyon Weir Site: Part 1. Monitoring Site Installation and Tracer Tests
86. Comparison of the Water Balance of an Asphalt Cover and an Evapotranspiration Cover at Technical Area 49 at the Los Alamos National Laboratory
87. In Vivo Pharmacodynamic Effects of Hu1D10 (Remitogen), a Humanized Antibody Reactive Against a Polymorphic Determinant of HLA-DR Expressed on B Cells
88. PHASE I TRIAL OF HuM291, A HUMANIZED ANTI-CD3 ANTIBODY, IN PATIENTS RECEIVING RENAL ALLOGRAFTS FROM LIVING DONORS1
89. A PHASE I/II MULTIPLE DOSE STUDY OF HuM291, A HUMANIZED ANTI-CD3 MONOCLONAL ANTIBODY, IN PATIENTS EXPERIENCING RENAL ALLOGRAFT REJECTION
90. PHASE I DOSE ESCALATION TRIAL OF HuM 291, A HUMANIZED ANTI-CD3 ANTIBODY, IN LIVING DONOR KIDNEY RECIPIENTS
91. Water use of two desert landscape tree species in Tucson, Arizona.
92. Paths to Glory : How Great Baseball Teams Got That Way
93. Modal depth anomalies from multibeam bathymetry: Is there a South Pacific superswell?
94. Evidence for diffuse extension of the Pacific Plate from Pukapuka ridges and cross‐grain gravity lineations
95. The Keystoners
96. A Phase I Study of Interleukin-2 in Children with Cancer
97. PHASE II TRIAL OF rIL-2 AND INF-ALPHA FOR MELANOMA, COLORECTAL CANCER AND RENAL CELL CANCER
98. Stepwise inversion of a groundwater flow model with multi-scale observation data.
99. Prolonged Interleukin-2 (IL-2) Treatment Can Augment Immune Activation Without Enhancing Antitumor Activity in Renal Cell Carcinom
100. In Vivo Pharmacodynamic Effects of Hu1D10 (Remitogen), a Humanized Antibody Reactive Against a Polymorphic Determinant of HLA-DR Expressed on B Cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.